The CDC has now released booster guidance for all three vaccines available in the U.S. — making tens of millions of people eligible for another shot. And on Tuesday, an FDA panel met to review data from Pfizer on their vaccine for children ages 5 - 11.
NPR's Alison Aubrey explains what those data say about the vaccine — and how it might be rolled out.
Pediatrician Dr. Reah Boyd tells NPR how she's talking to parents about vaccinating their young children.